Jacobs Solutions (J)
搜索文档
Jacobs Awarded FBI Information Technology Supplies and Support Services Contract
Prnewswire· 2024-07-24 19:45
Strengthens government operations by leveraging innovative data and security solutions DALLAS, July 24, 2024 /PRNewswire/ -- Jacobs (NYSE:J) was awarded the competitive Federal Bureau of Investigation (FBI) Information Technology Supplies and Support Services 2nd Generation (ITSSS-2) Blanket Purchase Agreement (BPA). This agreement, which will also be available to the broader Department of Justice, provides critical IT support to the FBI. The contract highlights Jacobs' nearly two-decade-long collaboration ...
Vice Admiral Mary Jackson Named to Jacobs Board of Directors
Prnewswire· 2024-07-19 03:25
Brings further strategic growth and operational efficiency business intelligenceDALLAS, July 18, 2024 /PRNewswire/ -- Jacobs (NYSE:J) announced today the election of Mary Jackson to its Board of Directors, effective upon the closing of the previously announced separation of Jacobs' Critical Mission Solutions and portions of its Divergent Solutions business, or, if earlier, January 15, 2025. A 32-year veteran of the United States Navy with extensive experience as an advisor across numerous boards while in th ...
Jacobs Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Critical Mission Solutions and Cyber & Intelligence Businesses and Merger with Amentum
Prnewswire· 2024-07-17 05:36
DALLAS, July 16, 2024 /PRNewswire/ -- Jacobs (NYSE: J) has announced that a Form 10 has been publicly filed with the U.S. Securities and Exchange Commission ("SEC") for the previously announced planned spin-off of its Critical Mission Solutions and portions of its Divergent Solutions business, including the Cyber & Intelligence business. Filed under Amazon Holdco Inc., the Form 10 describes the spin-off and merger with Amentum Parent Holdings LLC ("Amentum"), to create a leading, publicly traded global engi ...
Jacobs to Hold Its Fiscal Third Quarter 2024 Earnings Conference Call and Webcast
Prnewswire· 2024-07-15 22:05
DALLAS, July 15, 2024 /PRNewswire/ -- Jacobs (NYSE:J) plans to release its fiscal third quarter 2024 earnings results before market open on Tuesday, Aug. 6, 2024, and will host a conference call at 10:00 a.m. ET, during which management will make a presentation focusing on the company's results and operating trends.Interested parties can listen to the conference call via a webcast and view accompanying slides at jacobs.com.About Jacobs At Jacobs, we're challenging today to reinvent tomorrow by solving the w ...
Jacobs Declares Quarterly Dividend
Prnewswire· 2024-07-12 05:40
DALLAS, July 11, 2024 /PRNewswire/ -- The Board of Directors of Jacobs (NYSE:J) has declared a quarterly cash dividend payable to shareholders in the amount of $0.29 per share of Jacobs common stock. This dividend will be paid on Aug. 23, 2024, to shareholders of record as of the close of business on July 26, 2024.About Jacobs At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operation ...
Jacobs Selected by Omaha Streetcar Authority for Transportation Project in Nebraska's Largest City
Prnewswire· 2024-07-11 19:45
Omaha streetcar project will connect downtown urban area to surrounding neighborhoods delivering lasting economic and environmental benefits DALLAS, July 11, 2024 /PRNewswire/ -- Jacobs (NYSE:J) was selected as Owner's Representative for the Omaha Streetcar Authority's streetcar project, which will establish transportation options and attract new growth in Omaha's urban core. Following an expected three-mile loop, the streetcar route will include more than 15 stops, providing a critical connection to downto ...
Jacobs Supports Draft Strategic Plan for Ireland's Water Services
Prnewswire· 2024-07-10 17:30
Strategic advisory project focused on resilient and sustainable water supply for the next 25 yearsDALLAS, July 10, 2024 /PRNewswire/ -- As External Services Provider, Jacobs (NYSE:J) is helping Uisce Éireann (previously known as Irish Water) to proactively plan the delivery of high quality, sustainable and resilient water services for Ireland through its Water Services Strategic Plan (WSSP) 2050.As Ireland's national public water services utility, Uisce Éireann is responsible for the operation and capital i ...
Jacobs Awarded Program Manager Owner Advisor Contract at King County South Treatment Plant in Washington State
Prnewswire· 2024-07-02 19:45
文章核心观点 - 公司获选为金县污水处理部门提供超过8亿美元关键基础设施升级项目的项目管理和咨询服务 [1][2][3][4] - 该项目将提升西雅图及普吉特湾地区约200万人的水质和系统抗灾能力 [3][4] - 公司在复杂基础设施项目管理方面拥有丰富经验,曾参与过多个重大水务项目 [4][5] 公司概况 - 公司是工程新闻记录杂志评选的第一大项目管理公司 [5] - 公司年收入约160亿美元,拥有6万多名员工,提供全方位专业服务 [6] 项目背景 - 金县污水处理部门的南部处理厂每天处理1.15亿加仑湿季和9600万加仑干季的污水,并设有1.5英亩的示范农场 [3] - 该项目是金县基础设施投资的跨代项目,体现了保护该地区水质的承诺 [4] 公司历史 - 公司曾参与过多个重大水务项目,如旧金山港滨水抗灾项目、泰晤士隧道项目、新西兰中央截流项目等 [5] - 公司10年前曾担任布赖特沃特处理厂的首席顾问,当时是北美最大的膜生物反应器 [4]
Jacobs (J) Secures Major Contract to Expand FUJIFILM Site
ZACKS· 2024-06-28 23:55
Jacobs Solutions, Inc. (J) has been selected by FUJIFILM Diosynth Biotechnologies to support the delivery of a $1.2 billion expansion project for their large-scale cell culture contract manufacturing site in Holly Springs, NC. This significant expansion builds on the initial collaboration started in 2021, further cementing the partnership between the two companies.Jacobs will provide comprehensive engineering, procurement, and construction management services for this latest phase. The project includes addi ...
Jacobs Selected to Support Delivery of $1.2B Expansion of FUJIFILM Diosynth Biotechnologies' Large-Scale Biologics Manufacturing Site
Prnewswire· 2024-06-27 19:45
文章核心观点 - 杰克逊公司(Jacobs)被FUJIFILM Diosynth Biotechnologies选中,支持在北卡罗来纳州Holly Springs建设一个价值12亿美元的大规模细胞培养合同制造基地的扩建项目 [1][2][3][4] - 该扩建项目将增加8个20,000升的细胞培养生物反应器和约40万平方英尺的制造空间,预计将于2025年完工 [3][4] - 该基地将成为北美最大的端到端细胞培养合同制造设施之一,将大幅提高FUJIFILM Diosynth Biotechnologies的生物制药产能 [4][5] 公司相关 - 杰克逊公司是一家提供专业服务的公司,包括咨询、技术、科学和项目交付,为政府和私营部门客户服务 [5] - 杰克逊公司年收入约160亿美元,拥有6万多名员工 [5] 行业相关 - FUJIFILM Diosynth Biotechnologies是一家生物制药公司,此次扩建项目将显著增加其生物制药产能 [4][5] - 该项目将提供药物原料制造、自动化灌装、包装和标签服务,以满足全球生物制药客户的需求 [5]